4.065
전일 마감가:
$4.36
열려 있는:
$4.32
하루 거래량:
628.08K
Relative Volume:
0.54
시가총액:
$243.42M
수익:
-
순이익/손실:
$-40.33M
주가수익비율:
-2.2709
EPS:
-1.79
순현금흐름:
$-39.53M
1주 성능:
+2.14%
1개월 성능:
+43.13%
6개월 성능:
+22.81%
1년 성능:
-15.84%
Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile
명칭
Eledon Pharmaceuticals Inc
전화
949-238-8090
주소
19800 MACARTHUR BLVD., IRVINE
ELDN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ELDN
Eledon Pharmaceuticals Inc
|
4.065 | 261.08M | 0 | -40.33M | -39.53M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.49 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
631.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.45 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
836.24 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.56 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-18 | 재개 | H.C. Wainwright | Buy |
| 2025-01-28 | 개시 | Guggenheim | Buy |
| 2022-05-13 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-03-23 | 개시 | Cantor Fitzgerald | Overweight |
Eledon Pharmaceuticals Inc 주식(ELDN)의 최신 뉴스
Can Eledon Pharmaceuticals Inc. stock resist sector downturnsInsider Selling & Weekly Watchlist for Consistent Profits - newser.com
Why Eledon Pharmaceuticals Inc. (2TK) stock stays on buy listsJuly 2025 Summary & Proven Capital Preservation Methods - newser.com
Real time scanner hits for Eledon Pharmaceuticals Inc. explainedJuly 2025 Earnings & Expert Verified Movement Alerts - newser.com
Will Eledon Pharmaceuticals Inc. stock gain from lower inflationMarket Trend Report & Capital Efficiency Focused Strategies - newser.com
How Eledon Pharmaceuticals Inc. (2TK) stock valuation compares with sector2025 Market WrapUp & Safe Entry Point Identification - newser.com
Published on: 2025-11-03 08:17:43 - newser.com
Market reaction to Eledon Pharmaceuticals Inc.’s recent news2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
Is Eledon Pharmaceuticals Inc. (2TK) stock attractive post correctionSwing Trade & Risk Managed Investment Strategies - newser.com
Using AI based signals to follow Eledon Pharmaceuticals Inc.Weekly Investment Report & Verified Short-Term Trading Plans - newser.com
Will Eledon Pharmaceuticals Inc. (2TK) stock beat revenue estimates2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com
Eledon Pharmaceuticals Inc. stock momentum explained2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
Visual trend scoring systems applied to Eledon Pharmaceuticals Inc.Weekly Trade Recap & Entry Point Confirmation Alerts - newser.com
Can Eledon Pharmaceuticals Inc. recover in the next quarterProfit Target & Verified Stock Trade Ideas - newser.com
Why Eledon Pharmaceuticals Inc. (2TK) stock could be top winnerDay Trade & Capital Protection Trade Alerts - newser.com
Why analysts remain bullish on Eledon Pharmaceuticals Inc. stockCPI Data & Daily Profit Maximizing Tips - newser.com
Eledon Pharmaceuticals Inc. stock daily chart insights2025 Market Sentiment & Consistent Income Trade Ideas - newser.com
How to build a dashboard for Eledon Pharmaceuticals Inc. stockTrade Volume Summary & Short-Term High Return Ideas - newser.com
Can Eledon Pharmaceuticals Inc. (2TK) stock double in coming yearsGap Down & Long-Term Investment Growth Plans - newser.com
Is Eledon Pharmaceuticals Inc. (2TK) stock supported by strong fundamentalsBull Run & Target Return Focused Stock Picks - newser.com
What dividend safety rating applies to Eledon Pharmaceuticals Inc. (2TK) stockMarket Volume Summary & Community Consensus Stock Picks - newser.com
Will breakout in Eledon Pharmaceuticals Inc. lead to full recoveryJuly 2025 Rallies & Real-Time Volume Spike Alerts - newser.com
Is Eledon Pharmaceuticals Inc. stock a buy in volatile marketsJuly 2025 Short Interest & High Conviction Trade Alerts - newser.com
Short Interest in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Declines By 47.4% - MarketBeat
Published on: 2025-11-01 03:53:10 - newser.com
Published on: 2025-10-31 05:05:04 - newser.com
Is this a good reentry point in Eledon Pharmaceuticals Inc.2025 Dividend Review & Free Accurate Trade Setup Notifications - newser.com
Eledon Pharmaceuticals’ AT 1501: A Promising Kidney Transplant Study Update - TipRanks
Eledon Pharmaceuticals Inc (ELDN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):